CryoLife Declares a Dividend of Approximately $0.87 on Its Convertible Preferred Stock

         Shareholders Reelect Current Board Members At Annual Meeting

ATLANTA, June 2 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials and biosurgical device company, announced today, that the Company declared a dividend of approximately $0.87 on its 6% convertible preferred stock payable on July 1, 2005, to shareholders of record at the close of business on June 20, 2005. At the Company's Annual Meeting, shareholders reelected the eight current members of the Board of Directors.

About CryoLife

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiovascular and vascular surgeries throughout the United States and Canada. The Company's BioGlue Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels and is CE marked in the European Community and approved in Canada for use in soft tissue repair and approved in Australia for use in vascular and pulmonary sealing and repair.

For additional information about the Company, visit CryoLife's Web site: http://www.cryolife.com

Contact: Joseph T. Schepers
Vice President, Corporate Communications
(770) 419-3355

SOURCE CryoLife, Inc.